Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE).
de Leeuw ALMP, Giralt J, Tao Y, Benavente S, France Nguyen TV, Hoebers FJP, Hoeben A, Terhaard CHJ, Wai Lee L, Friesland S, Steenbakkers RJHM, Tans L, Heukelom J, Kayembe MT, van Kranen SR, Bartelink H, Rasch CRN, Sonke JJ, Hamming-Vrieze O. de Leeuw ALMP, et al. Among authors: terhaard chj. Radiother Oncol. 2024 Apr 16;196:110281. doi: 10.1016/j.radonc.2024.110281. Online ahead of print. Radiother Oncol. 2024. PMID: 38636708
Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of 18F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.
van den Bosch S, Dijkema T, Philippens MEP, Terhaard CHJ, Hoebers FJP, Kaanders JHAM, Oyen WJG. van den Bosch S, et al. Among authors: terhaard chj. Radiother Oncol. 2019 Jan;130:39-45. doi: 10.1016/j.radonc.2018.06.037. Epub 2018 Jul 10. Radiother Oncol. 2019. PMID: 30005954 Free article.
Dose response modelling of secretory cell loss in salivary glands using PSMA PET.
Mohan V, Bruin NM, Steenbakkers RJHM, Noordzij W, Terhaard CHJ, de Keizer B, Al-Mamgani A, van de Kamer JB, Sonke JJ, Vogel WV. Mohan V, et al. Among authors: terhaard chj. Radiother Oncol. 2022 Dec;177:164-171. doi: 10.1016/j.radonc.2022.10.038. Epub 2022 Nov 8. Radiother Oncol. 2022. PMID: 36368471 Free article.
Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer.
de Roest RH, van der Heijden M, Wesseling FWR, de Ruiter EJ, Heymans MW, Terhaard C, Vergeer MR, Buter J, Devriese LA, de Boer JP, Navran A, Hoeben A, Vens C, van den Brekel M, Brakenhoff RH, Leemans CR, Hoebers F. de Roest RH, et al. Radiother Oncol. 2022 Oct;175:112-121. doi: 10.1016/j.radonc.2022.08.013. Epub 2022 Aug 13. Radiother Oncol. 2022. PMID: 35973619 Free article.
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
van den Bosch S, Dijkema T, Kunze-Busch MC, Terhaard CH, Raaijmakers CP, Doornaert PA, Hoebers FJ, Vergeer MR, Kreike B, Wijers OB, Oyen WJ, Kaanders JH. van den Bosch S, et al. BMC Cancer. 2017 Mar 21;17(1):208. doi: 10.1186/s12885-017-3195-7. BMC Cancer. 2017. PMID: 28327089 Free PMC article. Clinical Trial.
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.
Langendijk JA, Hoebers FJP, de Jong MA, Doornaert P, Terhaard CHJ, Steenbakkers RJHM, Hamming-Vrieze O, van de Kamer JB, Verbakel WFAR, Keskin-Cambay F, Reitsma JB, van der Schaaf A, Boersma LJ, Schuit E. Langendijk JA, et al. Among authors: terhaard chj. Int J Part Ther. 2021 Jun 25;8(1):354-365. doi: 10.14338/IJPT-20-00089.1. eCollection 2021 Summer. Int J Part Ther. 2021. PMID: 34285961 Free PMC article.
Multicenter validation of recursive partitioning analysis classification for patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Jonkman A, Kaanders JH, Terhaard CH, Hoebers FJ, van den Ende PL, Wijers OB, Verhoef LC, de Jong MA, Leemans CR, Langendijk JA. Jonkman A, et al. Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):119-25. doi: 10.1016/j.ijrobp.2006.12.002. Int J Radiat Oncol Biol Phys. 2007. PMID: 17448870
18F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival.
van den Bosch S, Doornaert PAH, Dijkema T, Zwijnenburg EM, Verhoef LCG, Hoeben BAW, Kasperts N, Smid EJ, Terhaard CHJ, Kaanders JHAM. van den Bosch S, et al. Among authors: terhaard chj. Radiother Oncol. 2020 Jan;142:107-114. doi: 10.1016/j.radonc.2019.07.025. Epub 2019 Aug 19. Radiother Oncol. 2020. PMID: 31439447 Free article.
Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
Willemsen ACH, Kok A, van Kuijk SMJ, Baijens LWJ, de Bree R, Devriese LA, Hoebers FJP, Lalisang RI, Schols AMWJ, Terhaard CHJ, Hoeben A. Willemsen ACH, et al. Among authors: terhaard chj. Clin Nutr. 2020 Aug;39(8):2600-2608. doi: 10.1016/j.clnu.2019.11.033. Epub 2019 Dec 3. Clin Nutr. 2020. PMID: 31839429
Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
Willemsen ACH, Kok A, Baijens LWJ, de Boer JP, de Bree R, Devriese LA, Driessen CML, van Herpen CML, Hoebers FJP, Kaanders JHAM, Karsten RT, van Kuijk SMJ, Lalisang RI, Navran A, Pereboom SR, Schols AMWJ, Terhaard CHJ, Hoeben A. Willemsen ACH, et al. Among authors: terhaard chj. Clin Nutr. 2022 Jan;41(1):177-185. doi: 10.1016/j.clnu.2021.11.019. Epub 2021 Nov 24. Clin Nutr. 2022. PMID: 34883306 Free article.
160 results